| 5.2 |
25.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 2.6 |
7.7 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 2.5 |
7.6 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 2.4 |
2.4 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 2.1 |
10.5 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 2.1 |
6.2 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 1.7 |
5.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 1.7 |
5.1 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 1.5 |
4.5 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 1.4 |
4.3 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 1.4 |
4.3 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 1.4 |
14.0 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 1.4 |
7.0 |
GO:0042637 |
catagen(GO:0042637) |
| 1.4 |
4.1 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 1.3 |
9.0 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 1.3 |
5.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.3 |
6.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.3 |
11.3 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.3 |
5.0 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 1.2 |
8.7 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 1.2 |
2.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 1.2 |
4.8 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.2 |
2.3 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 1.2 |
1.2 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.1 |
5.5 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 1.1 |
3.3 |
GO:0036233 |
glycine import(GO:0036233) |
| 1.1 |
3.2 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 1.1 |
8.5 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) |
| 1.1 |
3.2 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 1.0 |
3.1 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.0 |
13.6 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 1.0 |
2.9 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 1.0 |
2.9 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.9 |
2.8 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.9 |
3.7 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.9 |
0.9 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.9 |
0.9 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.9 |
9.0 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.9 |
2.7 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.9 |
0.9 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.9 |
7.0 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.9 |
2.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.9 |
1.7 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.8 |
0.8 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.8 |
2.5 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.8 |
0.8 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.8 |
3.3 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 0.8 |
3.3 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.8 |
4.9 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.8 |
3.2 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.8 |
3.2 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.8 |
3.9 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.8 |
1.5 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.8 |
2.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.7 |
2.2 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.7 |
0.7 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) |
| 0.7 |
3.7 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.7 |
1.5 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.7 |
2.9 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.7 |
3.7 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.7 |
2.9 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.7 |
2.2 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 |
2.2 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.7 |
2.1 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.7 |
0.7 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 0.7 |
4.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.7 |
4.1 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.7 |
2.0 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.7 |
2.0 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) interleukin-1 alpha secretion(GO:0050703) |
| 0.7 |
7.3 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.7 |
0.7 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.6 |
1.9 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.6 |
2.6 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.6 |
2.6 |
GO:0034135 |
regulation of toll-like receptor 2 signaling pathway(GO:0034135) positive regulation of defense response to bacterium(GO:1900426) |
| 0.6 |
2.6 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.6 |
2.5 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.6 |
1.9 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.6 |
0.6 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.6 |
2.5 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.6 |
1.8 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.6 |
1.8 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.6 |
4.2 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.6 |
0.6 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.6 |
1.8 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.6 |
1.2 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.6 |
2.3 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.6 |
2.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.6 |
6.4 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.6 |
2.9 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.6 |
2.9 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.6 |
0.6 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.6 |
1.7 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.6 |
1.7 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.6 |
1.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
0.6 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.6 |
1.1 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.6 |
1.7 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.6 |
1.7 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.6 |
2.8 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.5 |
1.1 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.5 |
2.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.5 |
1.6 |
GO:0002606 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.5 |
1.6 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) negative regulation of lymphocyte migration(GO:2000402) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.5 |
12.9 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.5 |
3.7 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.5 |
1.6 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.5 |
1.1 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.5 |
3.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.5 |
3.1 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.5 |
18.1 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.5 |
0.5 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.5 |
0.5 |
GO:0045851 |
pH reduction(GO:0045851) |
| 0.5 |
1.0 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.5 |
0.5 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.5 |
2.5 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
2.0 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.5 |
7.8 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.5 |
1.5 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.5 |
0.5 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.5 |
3.4 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.5 |
1.9 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.5 |
1.4 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 |
1.9 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.5 |
3.7 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.5 |
1.8 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.5 |
1.8 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.5 |
1.8 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.5 |
1.8 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.5 |
6.4 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.5 |
0.9 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.5 |
1.4 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.5 |
1.4 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.4 |
3.6 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.4 |
0.4 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.4 |
1.3 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 |
1.3 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.4 |
1.3 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.4 |
4.4 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.4 |
1.3 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.4 |
1.7 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.4 |
0.9 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) |
| 0.4 |
1.3 |
GO:0072338 |
creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.4 |
1.3 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.4 |
2.5 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.4 |
9.2 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.4 |
0.4 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.4 |
1.6 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.4 |
0.8 |
GO:0046618 |
drug export(GO:0046618) |
| 0.4 |
0.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 |
1.2 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.4 |
3.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.4 |
3.2 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.4 |
1.2 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.4 |
2.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.4 |
3.2 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.4 |
0.8 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 |
1.2 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.4 |
4.3 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.4 |
1.2 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.4 |
1.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.4 |
1.5 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.4 |
2.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.4 |
1.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.4 |
2.3 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.4 |
2.2 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.4 |
0.7 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.4 |
0.4 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.4 |
1.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 |
0.4 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.4 |
1.8 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 |
1.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.4 |
1.4 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.4 |
1.1 |
GO:0034476 |
U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.4 |
1.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
1.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.4 |
1.1 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
0.7 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 0.4 |
1.8 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
1.7 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.3 |
0.3 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.3 |
2.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
0.7 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 |
1.0 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.3 |
1.7 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.3 |
1.0 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
1.4 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
1.7 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.3 |
1.4 |
GO:0072235 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
| 0.3 |
0.7 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.3 |
1.0 |
GO:1902031 |
regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
0.7 |
GO:0045764 |
positive regulation of cellular amino acid metabolic process(GO:0045764) |
| 0.3 |
1.3 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.3 |
1.0 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.3 |
1.3 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 |
1.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 |
1.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.3 |
1.0 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.3 |
0.3 |
GO:0048289 |
negative regulation of isotype switching(GO:0045829) isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.3 |
1.3 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.3 |
1.0 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 |
1.0 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.3 |
1.0 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.3 |
0.6 |
GO:1902219 |
maintenance of blood-brain barrier(GO:0035633) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 |
1.0 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 |
3.2 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.3 |
0.3 |
GO:0071220 |
response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.3 |
0.6 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.3 |
1.3 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.3 |
0.9 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.3 |
4.1 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.3 |
0.6 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 |
0.9 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.3 |
2.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
0.9 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.3 |
0.9 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 0.3 |
0.9 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.3 |
2.2 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 |
0.3 |
GO:0034370 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
| 0.3 |
0.9 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
2.2 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.3 |
0.9 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.3 |
0.9 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.3 |
0.9 |
GO:0030421 |
defecation(GO:0030421) |
| 0.3 |
1.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.3 |
1.2 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.3 |
0.6 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.3 |
1.2 |
GO:1904426 |
positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.3 |
0.6 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.3 |
1.2 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.3 |
1.2 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.3 |
1.2 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.3 |
1.5 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 |
1.1 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.3 |
0.9 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.3 |
0.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.3 |
2.6 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 |
0.3 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.3 |
2.0 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.3 |
0.8 |
GO:0097402 |
regulation of neural retina development(GO:0061074) neuroblast migration(GO:0097402) |
| 0.3 |
3.9 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.3 |
1.7 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 |
11.2 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.3 |
2.8 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.3 |
2.5 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.3 |
0.8 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.3 |
0.6 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.3 |
2.5 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 |
4.7 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.3 |
1.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.3 |
0.8 |
GO:0006296 |
base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.3 |
0.5 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.3 |
0.8 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.3 |
1.3 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.3 |
0.3 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.3 |
0.5 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 |
1.6 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.3 |
0.5 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.3 |
2.4 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.3 |
0.5 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.3 |
0.5 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.3 |
1.0 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.3 |
0.5 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.3 |
1.0 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 |
0.8 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.3 |
1.8 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.3 |
1.3 |
GO:0019659 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.3 |
1.3 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.3 |
1.8 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.3 |
1.0 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
0.7 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.2 |
1.2 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
1.7 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.2 |
1.5 |
GO:0042511 |
positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.2 |
1.0 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.2 |
2.4 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.2 |
0.7 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.2 |
0.7 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.2 |
1.9 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.2 |
0.5 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 |
0.7 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
1.0 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
1.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.2 |
1.0 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 |
0.7 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 |
0.7 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 |
0.7 |
GO:0030431 |
sleep(GO:0030431) |
| 0.2 |
0.7 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
1.2 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 |
0.5 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.2 |
0.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
2.3 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.2 |
1.2 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.2 |
2.5 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.2 |
1.4 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.2 |
0.9 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.2 |
1.1 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.2 |
0.9 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
1.6 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.2 |
0.7 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.2 |
0.7 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.2 |
0.7 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.2 |
0.9 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 |
3.8 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.2 |
3.1 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
4.2 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
4.2 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
0.7 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.2 |
1.1 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.2 |
0.9 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.2 |
0.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.2 |
2.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 |
0.7 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.2 |
0.4 |
GO:0035793 |
cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.2 |
1.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
1.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
3.2 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.2 |
0.6 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.9 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
2.1 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.2 |
0.6 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.2 |
0.2 |
GO:0055119 |
relaxation of cardiac muscle(GO:0055119) |
| 0.2 |
2.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 |
1.1 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.2 |
0.6 |
GO:0002883 |
regulation of type I hypersensitivity(GO:0001810) hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) type I hypersensitivity(GO:0016068) |
| 0.2 |
2.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
0.4 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.2 |
2.1 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 |
2.3 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.2 |
0.8 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
1.4 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.2 |
1.0 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
1.6 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
1.0 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
0.4 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.2 |
3.0 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.2 |
0.6 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
1.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.2 |
0.6 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.2 |
0.4 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 |
2.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
1.6 |
GO:0090177 |
establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.2 |
0.8 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.2 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
3.8 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.2 |
1.3 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.2 |
0.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
2.3 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
0.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.8 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
2.5 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 |
1.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
5.7 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.2 |
0.6 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.2 |
1.3 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
0.9 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
0.9 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 |
0.9 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.2 |
0.6 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 |
0.6 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.2 |
0.7 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
3.9 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.2 |
0.9 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.2 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
0.4 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.2 |
0.5 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.2 |
0.9 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 |
2.0 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
0.5 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
| 0.2 |
1.6 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.2 |
2.0 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.2 |
0.7 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.2 |
3.4 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.2 |
2.7 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
0.5 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 |
0.7 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.2 |
1.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
2.3 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 |
0.7 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
0.7 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.2 |
0.9 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.2 |
1.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.2 |
3.0 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.2 |
2.9 |
GO:1901032 |
negative regulation of response to reactive oxygen species(GO:1901032) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.2 |
4.7 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.2 |
0.3 |
GO:1904395 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 |
0.5 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.2 |
1.9 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.2 |
4.0 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.2 |
1.0 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 |
0.9 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
0.7 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.2 |
0.7 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.2 |
1.4 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.2 |
0.3 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.2 |
0.3 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.2 |
3.4 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
0.7 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.2 |
0.7 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
1.0 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.3 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.2 |
0.3 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
0.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.2 |
0.5 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.2 |
0.7 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.2 |
0.7 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 |
1.8 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.2 |
2.6 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.2 |
0.3 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
0.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
0.8 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.2 |
0.5 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
0.5 |
GO:0048563 |
post-embryonic organ morphogenesis(GO:0048563) |
| 0.2 |
0.5 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.2 |
2.2 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.2 |
0.5 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.2 |
1.3 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.2 |
2.2 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 |
1.6 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.2 |
0.6 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.2 |
3.6 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 |
0.3 |
GO:0032717 |
negative regulation of interleukin-8 production(GO:0032717) |
| 0.2 |
0.3 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.2 |
0.5 |
GO:0055012 |
ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.2 |
0.6 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.2 |
0.8 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.2 |
0.5 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.2 |
0.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.2 |
0.5 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.2 |
0.8 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 |
1.5 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
1.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
0.5 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
0.9 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
1.1 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 |
1.4 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.9 |
GO:1903961 |
positive regulation of anion transmembrane transport(GO:1903961) |
| 0.1 |
2.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.3 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 |
0.6 |
GO:0045606 |
positive regulation of epidermal cell differentiation(GO:0045606) |
| 0.1 |
1.0 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
0.4 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.9 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
1.0 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.1 |
0.1 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.1 |
0.7 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.4 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.1 |
3.3 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 |
0.4 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 |
0.1 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.1 |
0.6 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.1 |
0.9 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.3 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
1.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 |
2.7 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
0.8 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.1 |
0.6 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
1.0 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.4 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
1.3 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
1.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.1 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.8 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.6 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.3 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.1 |
0.1 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.1 |
0.6 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.6 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
1.1 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
2.6 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 0.1 |
0.4 |
GO:0051892 |
regulation of cardioblast differentiation(GO:0051890) negative regulation of cardioblast differentiation(GO:0051892) |
| 0.1 |
0.3 |
GO:0072224 |
metanephric glomerulus development(GO:0072224) |
| 0.1 |
0.1 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 |
2.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.5 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
1.8 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.9 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.7 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.5 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.5 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.8 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.5 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.5 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.1 |
2.0 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 |
0.3 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.1 |
0.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.5 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.1 |
0.5 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.9 |
GO:0032261 |
purine nucleotide salvage(GO:0032261) |
| 0.1 |
0.3 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
1.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.4 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
1.4 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.1 |
1.2 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.1 |
0.6 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.4 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
2.0 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.1 |
0.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.1 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
2.0 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.4 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
1.1 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.1 |
0.5 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 |
0.4 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.1 |
1.6 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.1 |
0.7 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
1.0 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.1 |
0.6 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
1.4 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.9 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.5 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 |
0.6 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.4 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
4.8 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
0.7 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
2.5 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
1.7 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.5 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
1.6 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.6 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.7 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
0.2 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.1 |
0.4 |
GO:0070255 |
regulation of mucus secretion(GO:0070255) |
| 0.1 |
0.5 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.4 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
1.4 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
0.9 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.3 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.1 |
4.5 |
GO:0055013 |
cardiac muscle cell development(GO:0055013) |
| 0.1 |
1.2 |
GO:0010574 |
vascular endothelial growth factor production(GO:0010573) regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 |
1.1 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.3 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
3.2 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
1.1 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.5 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 |
0.8 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.1 |
0.6 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
0.9 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.4 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.1 |
0.7 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
1.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.8 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
1.6 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.1 |
0.1 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 0.1 |
0.7 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.8 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
1.0 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
2.1 |
GO:1901661 |
quinone metabolic process(GO:1901661) |
| 0.1 |
0.4 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
1.0 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.1 |
0.6 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 |
0.2 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.1 |
0.6 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.1 |
1.1 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.3 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.4 |
GO:0006563 |
L-serine metabolic process(GO:0006563) |
| 0.1 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.3 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.1 |
0.3 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.1 |
0.1 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.5 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
2.5 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.1 |
0.4 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.1 |
0.4 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
0.8 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.1 |
1.7 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.2 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.5 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.3 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
0.3 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.4 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.1 |
0.3 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
1.0 |
GO:0043482 |
pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.1 |
0.3 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
1.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.9 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.1 |
1.0 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.1 |
1.0 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.1 |
0.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.4 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.4 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
0.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
0.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.3 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 |
0.5 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.5 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
0.4 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
2.6 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.1 |
0.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.9 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.5 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.8 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.1 |
2.3 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 |
0.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
1.3 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 |
0.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.8 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.7 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.2 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
1.0 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) |
| 0.1 |
0.3 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.1 |
0.1 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 |
0.4 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.3 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.1 |
1.0 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.1 |
0.8 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.6 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.1 |
1.1 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
2.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
0.2 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) mitral valve formation(GO:0003192) |
| 0.1 |
0.4 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
0.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.4 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
1.9 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.5 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
1.3 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.2 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.1 |
0.3 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 |
1.8 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
1.4 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.1 |
0.5 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.8 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.1 |
0.2 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.1 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.5 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 |
0.8 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
0.5 |
GO:0090151 |
establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 |
0.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.1 |
1.2 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
0.8 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.4 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.1 |
0.5 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
| 0.1 |
0.4 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.5 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.3 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 |
0.2 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 |
0.6 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.7 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.5 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.1 |
0.4 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
1.0 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
1.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
2.2 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.4 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
1.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
1.5 |
GO:0038061 |
NIK/NF-kappaB signaling(GO:0038061) |
| 0.1 |
0.2 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.1 |
0.3 |
GO:0070723 |
response to cholesterol(GO:0070723) |
| 0.1 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.3 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
1.5 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.5 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.3 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.9 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 |
0.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
0.3 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.7 |
GO:1904851 |
positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.1 |
0.3 |
GO:0061307 |
cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
| 0.1 |
0.2 |
GO:0018216 |
peptidyl-arginine methylation(GO:0018216) |
| 0.1 |
0.6 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.5 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.7 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.7 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 |
1.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
2.5 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.4 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 |
0.6 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
0.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.3 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
0.5 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.1 |
0.1 |
GO:1904468 |
negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.1 |
0.4 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.1 |
1.0 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 |
0.3 |
GO:0060179 |
inter-male aggressive behavior(GO:0002121) male mating behavior(GO:0060179) |
| 0.1 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.4 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 |
0.5 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.2 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 |
0.2 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 |
0.1 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.1 |
1.1 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
0.1 |
GO:0036336 |
dendritic cell chemotaxis(GO:0002407) myeloid dendritic cell chemotaxis(GO:0002408) dendritic cell migration(GO:0036336) |
| 0.1 |
0.2 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
0.3 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 |
0.3 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.2 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.1 |
0.5 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.1 |
0.5 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
0.2 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.9 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.3 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 0.1 |
5.6 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.2 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.2 |
GO:2000768 |
glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.1 |
0.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
1.3 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 |
0.8 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.2 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.9 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.2 |
GO:0051409 |
response to nitrosative stress(GO:0051409) cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
0.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.2 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.1 |
0.3 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.1 |
0.3 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.1 |
0.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
1.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.7 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.1 |
0.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.2 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.1 |
0.6 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.1 |
GO:0061515 |
myeloid cell development(GO:0061515) |
| 0.0 |
0.5 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.0 |
0.2 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.0 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.0 |
2.0 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.2 |
GO:0072512 |
ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.0 |
1.6 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
0.0 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.0 |
0.7 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
1.2 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.2 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.2 |
GO:0023021 |
termination of signal transduction(GO:0023021) termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.7 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.7 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.3 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.0 |
0.2 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of immunoglobulin secretion(GO:0051023) negative regulation of immunoglobulin secretion(GO:0051025) regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) response to L-glutamate(GO:1902065) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.3 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.0 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.0 |
0.3 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.4 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.1 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
1.4 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.0 |
0.2 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.0 |
1.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.3 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.3 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.5 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 |
1.7 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.1 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.9 |
GO:0031063 |
regulation of histone deacetylation(GO:0031063) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.2 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.0 |
0.9 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.2 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.2 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
1.5 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.0 |
0.1 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.0 |
0.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
2.9 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.5 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.0 |
0.5 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.0 |
0.7 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.5 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.4 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.0 |
0.1 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.0 |
GO:2000343 |
positive regulation of receptor biosynthetic process(GO:0010870) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.0 |
0.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.5 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.1 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.9 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.2 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.0 |
0.3 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.1 |
GO:0010002 |
cardioblast differentiation(GO:0010002) cardiac muscle cell myoblast differentiation(GO:0060379) |
| 0.0 |
0.3 |
GO:1901984 |
negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.0 |
0.4 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.0 |
0.1 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.4 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.2 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.5 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.4 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.2 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.2 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 |
0.5 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.0 |
0.1 |
GO:0030168 |
platelet activation(GO:0030168) |
| 0.0 |
0.5 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.0 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.3 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.2 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.0 |
0.4 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.0 |
0.5 |
GO:0031952 |
regulation of protein autophosphorylation(GO:0031952) |
| 0.0 |
0.1 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.0 |
0.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.0 |
0.3 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.4 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.4 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.0 |
0.4 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.0 |
0.2 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
0.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.1 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.0 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.2 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.0 |
0.5 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.0 |
0.2 |
GO:0046660 |
female sex differentiation(GO:0046660) |
| 0.0 |
0.4 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.2 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.2 |
GO:0060674 |
placenta blood vessel development(GO:0060674) |
| 0.0 |
0.0 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.0 |
0.2 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.1 |
GO:0060439 |
trachea morphogenesis(GO:0060439) trachea formation(GO:0060440) regulation of Golgi inheritance(GO:0090170) |
| 0.0 |
0.2 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 |
0.2 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.1 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.4 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 |
0.1 |
GO:0006448 |
regulation of translational elongation(GO:0006448) |
| 0.0 |
1.2 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.0 |
GO:2001181 |
positive regulation of T-helper 2 cell differentiation(GO:0045630) regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.1 |
GO:0007128 |
M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.0 |
0.2 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.4 |
GO:0021514 |
ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.0 |
0.0 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.1 |
GO:0090207 |
regulation of triglyceride metabolic process(GO:0090207) |
| 0.0 |
0.0 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.0 |
0.1 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.1 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.2 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.1 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.1 |
GO:0006677 |
glycosylceramide metabolic process(GO:0006677) |
| 0.0 |
0.3 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.0 |
0.1 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.0 |
0.1 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.3 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.3 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.4 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.2 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.4 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.4 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.3 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.0 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.1 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 |
0.1 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.3 |
GO:0043038 |
amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.1 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.3 |
GO:2000816 |
negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.4 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
